A Phase 3 interventional study of Next Generation Ophthalmic Irrigating Solution (NGOIS) and BSS Plus in Eye Diseases, sponsored by Alcon Research. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-03-05.
Sponsored by Alcon Research · Phase 3, Interventional, and Treatment
The purpose of this study is to evaluate the safety of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS PLUS for use during surgery for removal of epimacular membrane and vitrectomy.
740 studies on the registry are indexed under Eye Diseases; 117 are open to participants now.
This study's enrollment of 369 is above the median of 68 across 547 interventional studies indexed under Eye Diseases.
Browse Eye Diseases studies →Alcon Research is the lead sponsor of 608 studies on the registry; 9 are open to participants now.
Of its 109 completed or terminated interventional studies of FDA-regulated products, 99 (91%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Next Generation Ophthalmic Irrigating Solution (NGOIS)
Other: BSS Plus
Volume sufficient to irrigate adequately during cataract surgery
Volume sufficient to irrigate adequately during cataract surgery
Best-corrected logMAR visual acuity
Intraocular pressure (IOP)
This study is completed, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Alcon Research